Biotechnology Jobs

• Baar Onyx
• Hybrid
• US$189,750 – US$316,250 pa
• Director

Leads the design and execution of clinical biomarker and translational medicine strategies for late-stage oncology assets, defining patient segmentation and decision criteria within Clinical Matrix Teams. Validates predictive, pharmacodynamic and resistance biomarkers using platforms such as NGS, FISH, PCR, IHC/IF, flow cytometry, liquid biopsy/ctDNA and multi-omic analyses, and oversees sample testing plans and biomarker data packages for clinical and regulatory decisions.

NGS · FISH · PCR +6

• USA - Pennsylvania - Upper Providence
• Hybrid
• US$189,750 – US$316,250 pa
• Director

Leads the design and execution of clinical biomarker and translational medicine strategies for late-stage oncology assets, defining patient segmentation and decision criteria within Clinical Matrix Teams. Validates predictive, pharmacodynamic and resistance biomarkers using platforms such as NGS, ctDNA, flow cytometry and multi-omic analyses to inform dose selection and go/no-go decisions.

IHC/IF · Liquid Biopsy · ctDNA +3

• London
• Hybrid · 2 days in office
• US$284,625 – US$474,375 pa
• Director · manages people

Leads clinical development medical activities for cardiovascular and vascular programs across early and late-phase studies, shaping clinical development plans, study designs and translational strategies. Serves as clinical lead for a matrix team, providing medical monitoring, regulatory input and safety oversight while working with biology, regulatory, commercial and operations colleagues.

• London
• Hybrid · 2 days in office
• US$222,750 – US$371,250 pa
• Director

Provides clinical and scientific leadership across cardiovascular clinical development programmes, shaping study designs, translational plans and regulatory documents within the Respiratory, Immunology & Inflammation Research Unit. Leads a Clinical Matrix Team, oversees participant safety and medical monitoring, and works cross-functionally with biology, regulatory, statistics and commercial partners. Hybrid working with at least two days per week on-site.

• Waltham, United States
• Hybrid · 2 days in office
• US$222,750 – US$371,250 pa
• Director

Leads clinical development strategy for cardiovascular assets within the Respiratory, Immunology & Inflammation Research Unit, designing clinical development plans, protocols and regulatory documents while providing medical monitoring and safety oversight. Chairs the Clinical Matrix Team and serves as primary clinical contact for regulators, investigators and key external experts across early and late-stage programs.

• Stevenage
• Hybrid · 2 days in office
• US$222,750 – US$371,250 pa
• Director · manages people

Provides clinical and scientific leadership across early-phase cardiovascular programs, shaping clinical development plans, study designs and regulatory documents. Leads a cross-functional Clinical Matrix Team, oversees medical monitoring and safety, and acts as the clinical point of contact for regulators, investigators and key external experts. Hybrid role with at least two days per week on-site.

• London
• Hybrid
• Director

Provides medical and scientific leadership for pharmacovigilance and risk management of oncology assets in clinical development, interpreting safety data, detecting signals and delivering benefit-risk recommendations. Represents Safety on cross-functional matrix teams and governance committees, and interacts with regulators. Hybrid UK-based role with mentoring and process-improvement duties.

• Belgium-Wavre
• Hybrid
• Director

Provides medical and scientific leadership for pharmacovigilance and risk management of oncology assets in clinical development, interpreting safety data, detecting signals and delivering benefit-risk recommendations. Represents Safety on cross-functional clinical matrix teams and governance committees, and may lead Safety Review Teams. Hybrid role based in the UK with global regulatory and partner interaction.

• London
• Hybrid · 2–3 days in office
• Director

Develops and executes global and regional regulatory strategies for assigned assets in the Respiratory, Immunology & Inflammation therapeutic group, managing regulatory interactions, submissions and review processes across regions. Ensures compliance with internal GSK processes and regulatory requirements to secure optimal labelling, working closely with global counterparts and commercial teams.

AI

• London
• Hybrid · 2–3 days in office
• US$187,275 – US$312,125 pa
• Director

Leads the scientific design and execution of interventional clinical studies within Medical Affairs, providing medical governance, safety data review and scientific oversight of protocols and analysis plans. Collaborates with cross-functional teams, investigators and thought leaders, and presents results for publications and regulatory submissions. Hybrid role with two to three days per week in office.

Digital Tools

• Waltham, United States
• Hybrid · 2–3 days in office
• US$187,275 – US$312,125 pa
• Director

Leads the scientific design and execution of interventional clinical studies within Medical Affairs, providing medical governance, safety data review and scientific oversight of protocols and analysis plans. Collaborates with cross-functional teams, investigators and thought leaders, and presents results for publications and regulatory submissions. Hybrid role with two to three days per week in office.

• Waltham, United States
• Hybrid · 2 days in office
• US$284,250 – US$473,750 pa
• Director · manages people

Leads a team of early clinical development medical directors and clinical scientists, owning Phase I/II clinical development plans including first-in-human, dose-escalation and proof-of-concept studies in lung and head/neck cancers. Bridges preclinical discovery and clinical development, driving translational and biomarker strategy, regulatory submissions and cross-functional matrix teams.

AI/ML

• Stevenage
• Hybrid · 2 days in office
• US$284,250 – US$473,750 pa
• Director · manages people

Leads a team of medical directors and clinical scientists designing and executing early-phase oncology trials, including first-in-human, dose-escalation and proof-of-concept studies, while bridging preclinical discovery and clinical development. Accountable for clinical development plans, benefit-risk, regulatory submissions and translational biomarker strategy across lung and head/neck cancer assets.

AI/ML

• Zug, Switzerland
• Hybrid · 2 days in office
• US$284,250 – US$473,750 pa
• Director · manages people

Leads a team of early clinical development medical directors and clinical scientists, owning Phase I/II clinical development plans including first-in-human, dose-escalation and proof-of-concept studies in lung and head/neck cancers. Bridges preclinical discovery and clinical development, driving translational and biomarker strategy with cross-functional and regulatory partners.

AI/ML

• London
• Hybrid · 2 days in office
• US$284,250 – US$473,750 pa
• Director · manages people

Leads a team of medical directors and clinical scientists designing and executing early-phase oncology trials, including first-in-human and proof-of-concept studies, while bridging preclinical discovery and clinical development. Accountable for clinical development plans, translational and biomarker strategy, and regulatory submissions across a lung and head/neck cancer portfolio.

AI/ML